Ex-Immunomedics CFO charged with insider trading
By 
Jaclyn Jaeger2021-12-03T19:58:00
The SEC charged former Immunomedics Chief Financial Officer Usama Malik and his former romantic partner with insider trading. The Department of Justice also announced criminal charges for securities fraud.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News2026 Excellence in Compliance Awards – Compliance Mentor of the Year finalists
What, exactly, makes a good mentor in compliance? Is it someone who supports your career? Someone who teaches you about how to handle ethical blind spots? Someone who can answer your questions, no matter how silly or naive? A good mentor offers some combination of guidance, compassion, wisdom, and straight ...
-
NewsCompliance pros Lomax, Kim added to the Compliance Week Advisory Board
Compliance Week has added Dr. Hemma R. Lomax of DocuSign and Boon Kim Fam of PVH Corp to its Advisory Board.
-
ArticleCFTC sues states to assert exclusive jurisdiction over prediction markets
The Commodity Futures Trading Commission filed lawsuits against Arizona, Connecticut, and Illinois last week over the jurisdiction of prediction markets, which have gained popularity in the past year.
More from Regulatory Enforcement
-
ArticleCMA holds companies responsible for false claims, fake reviews ‘throughout supply chain’
Companies face large fines if they spread false marketing claims or fake reviews about their products and services—as well as those by suppliers—under a toughened competition regime in the U.K. aimed at enhancing consumer protection.
-
ArticleFTC warns VISA and other processors that company policies may lead to debanking
Visa, Mastercard, PayPal, and Stripe have received letters from the Federal Trade Commission, warning the companies to end any policies or terms of service that may result in the “debanking” of customers.
-
ArticleDOJ makes good on corporate-friendly enforcement policy with Balt resolution
The ink was barely dry on the U.S. Department of Justice’s new corporate enforcement policy (CEP) when the agency announced it would not prosecute Balt SAS for alleged bribery violations.